Alia Rashid

WORK HISTORY

EDUCATION

SKILLS

ABOUT ALIA RASHID

British-trained physician specializing in ophthalmology, ophthalmic pathology, and ophthalmic imaging.Currently Vice President, Clinical Development at Ascidian Therapeutics, developing clinical studies to bring exon-editing therapies to patients with inherited retinal degenerations. Recently Senior Director, Clinical Development Lead for Ophthalmology at Editas Medicine focused on AAV CRISPR/Cas9 therapy for Leber Congenital Amaurosis type 10. Previously, Medical Director at Annexon Biosciences. Developing and designing clinical trials for complement-mediated neurodegenerative diseases. Previous role as Medical Director at Avalanche Biotechnologies. Responsibilities included designing clinical trials for gene therapies for AMD, and developing digital innovations to streamline and improve the drug development process.Pharmaceutical and biotechnology experience at Genentech as a clinical development physician in both the clinical science and medical affairs areas of clinical development. Lead physician for Innovations team. Provided ophthalmology expertise for Google Glass in Healthcare challenge, speaker at a Kaiser Externship Speaker Series on the Future of Healthcare Technology, Guest Lecturer at UC Berkeley on The Future of Healthcare, and published articles on medical innovation. Passionate about Digital Healthcare Innovation.Named to Top 10 Healthcare Trendsetters for 2016 by Medtech Boston https://medtechboston.medstro.com/blog/2016/02/03/top-10-healthcare-trendsetters-of-2016/11/Named to 2016 Medtech Boston 40 under 40 Healthcare Innovators listhttps://medtechboston.medstro.com/blog/2016/05/02/the-2016-medtech-boston-40-under-40-healthcare-innovators/30/